We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 21

Health Canada invites public comments on new post-market reporting regulations
  • Gowling WLG
  • USA, Canada
  • August 9 2018

The medical device industry in America and perceived shortcomings in the US Food and Drug Administration's ("FDA") approval process have recently come


Labelling of raw milk cheese
  • Gowling WLG
  • USA, Canada
  • September 12 2016

The science keeps piling up. It is not safe to consume raw milk and its products. The U.S. Food and Drug Administration (FDA) recently announced


3D-printed food when will the laws take shape?
  • Gowling WLG
  • USA, Canada
  • September 12 2016

3D printing is the new buzz technology being used to replicate human tissues, fighter jet parts, and human prosthetics. The technology is also


Cybersecurity and medical devices: Electronic medical data increases product liability risk for medical device manufacturers
  • Gowling WLG
  • USA, Canada
  • May 3 2016

The value of stolen personal health information is ten to twenty times greater than a stolen credit card number.1 As the health-care industry


Some Canadian biotech companies unhappy with length of FDA approval process
  • Gowling WLG
  • USA, Canada
  • May 29 2008

Canadian biotech companies amongst other countries' companies are reported recently to have been indicating their unhappiness with the speed with which the FDA is approving new drugs.


Isabel Raasch
  • Gowling WLG


Josh Hanet
  • Gowling WLG


Erin D. Farrell
  • Gowling WLG